×
Site Menu
Everything
Politics
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Health
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
2 days ago
7
The EU support of Imfinzi for early-stage gastric and gastroesophageal cancers expands the statement of 1 of the company’s top-selling oncology medicines.
Read Entire Article
Homepage
Technology
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
Related
Silicon Valley Musters Behind-the-Scenes Support for Anthrop...
4 hours ago
1
How common are fireballs streaking across the sky?
5 hours ago
1
Cryptocurrency, AI industries tested their influence in Illi...
6 hours ago
1
Popular
In a matter of hours, the White House changed its position o...
6 days ago
17
Duke, Arizona, Michigan and Florida lead title odds for Marc...
2 days ago
15
Oscars 2026: ‘One Battle After Another’ triumphs - Full resu...
2 days ago
15
The City That Inspired Rothko (It’s Not New York)
4 days ago
14
Air China to resume flights to North Korea at the end of the...
4 days ago
14